Table 4 Prevalence of mutations conferring resistance to CQ and SP in Plasmodium falciparum according age
Molecular marker | Symptomatic | Asymptomatic | ||
|---|---|---|---|---|
< 10 ans | ≥ 10 ans | < 10 ans | ≥ 10 ans | |
T 76 | 53 (94.6%) | 15 (93.8%) | 74 (91.4%) | 58 (96.7%) |
Y86 | 25 (45.5%) | 4 (25%)* | 49 (60.5%) | 43 (71.7%) |
T76 + Y86 | 24 (43.6%) | 4 (25%)** | 47 (58.8%) | 42 (70%) |
G437 | 36 (64.3%) | 12 (70.6%) | 54 (68.4%) | 48 (82.8%) |
E540 | 0% | 0% | 0% | 0% |
I51 | 52 (92.9%) | 17 (100) | 77 (96.2%) | 58 (98.3%) |
R59 | 53 (94.6%) | 16 (94.1%) | 77 (96.2%) | 53 (89.8%) |
N108 | 54 (96.4%) | 17 (100) | 78 (97.5%) | 58 (98.3%) |
IRN1 | 51 (91.1%) | 16 (94.1%) | 76 (95%) | 51 (86.4%) |
IRNG2 | 33 (58.9%) | 11 (64.7%) | 52 (65.8%) | 42 (72.4%) |